Tuhina Neogi, MD, PhD; Ted R. Mikuls, MD, MSPH
Grant Support: By grants P60 AR47785 (Dr. Neogi) and P50 AR060772 (Dr. Mikuls) from the National Institutes of Health.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-2401.
Requests for Single Reprints: Tuhina Neogi, MD, PhD, Clinical Epidemiology Unit and Rheumatology, Boston University School of Medicine, 650 Albany Street, Suite X200, Boston, MA 02118.
Current Author Addresses: Dr. Neogi: Clinical Epidemiology Unit and Rheumatology, Boston University School of Medicine, 650 Albany Street, Suite X200, Boston, MA 02118.
Dr. Mikuls: Department of Internal Medicine and Division of Rheumatology, University of Nebraska Medical Center, 986270 Nebraska Medical Center, Omaha, NE 68198-6270.
Neogi T, Mikuls TR. To Treat or Not to Treat (to Target) in Gout. Ann Intern Med. 2017;166:71–72. [Epub ahead of print 1 November 2016]. doi: https://doi.org/10.7326/M16-2401
Download citation file:
Published: Ann Intern Med. 2017;166(1):71-72.
Published at www.annals.org on 1 November 2016
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use